This brand name is authorized in Brazil
The drug CAPILAREMA contains one active pharmaceutical ingredient (API):
|
1
Aminaftone
UNII 03JLX11PE9 - AMINAPHTHONE
|
|
4-aminobenzoic acid (also known as para-aminobenzoic acid or PABA because the two functional groups are attached to the benzene ring across from one another in the para position) is an aminobenzoic acid in which the amino group is para to the carboxy group. PABA is an intermediate in the synthesis of folate by bacteria, plants, and fungi. The potassium salt is used as a drug against fibrotic skin disorders, such as Peyronie’s disease. PABA is also occasionally used in pill form by sufferers of irritable bowel syndrome to treat its associated gastrointestinal symptoms, and in nutritional epidemiological studies to assess the completeness of 24-hour urine collection for the determination of urinary sodium, potassium, or nitrogen levels. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C05CX | Other capillary stabilizing agents | C Cardiovascular system → C05 Vasoprotectives → C05C Capillary stabilizing agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 521000801113310, 521000803116317, 521018010009603 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
